Neil H Riordan

5.0k total citations · 1 hit paper
83 papers, 3.7k citations indexed

About

Neil H Riordan is a scholar working on Nutrition and Dietetics, Molecular Biology and Genetics. According to data from OpenAlex, Neil H Riordan has authored 83 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Nutrition and Dietetics, 25 papers in Molecular Biology and 21 papers in Genetics. Recurrent topics in Neil H Riordan's work include Vitamin C and Antioxidants Research (27 papers), Mesenchymal stem cell research (20 papers) and Vitamin D Research Studies (12 papers). Neil H Riordan is often cited by papers focused on Vitamin C and Antioxidants Research (27 papers), Mesenchymal stem cell research (20 papers) and Vitamin D Research Studies (12 papers). Neil H Riordan collaborates with scholars based in United States, Canada and Panama. Neil H Riordan's co-authors include Thomas E. Ichim, K. S. Rao, Xiaolong Meng, Hugh D. Riordan, Joseph J Casciari, Nina Mikirova, Kyle Chan, Michael J. González, Jorge R. Miranda-Massari and Amit N. Patel and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Cancer and American Journal of Transplantation.

In The Last Decade

Neil H Riordan

83 papers receiving 3.5k citations

Hit Papers

A review of therapeutic effects of mesenchymal stem cell ... 2014 2026 2018 2022 2014 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods
    2014 477 citations Neil H Riordan et al. Journal of Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil H Riordan United States 32 1.4k 1.2k 931 711 485 83 3.7k
Noboru Fukuda Japan 36 698 0.5× 2.1k 1.8× 831 0.9× 159 0.2× 400 0.8× 234 4.4k
Román Pérez-Fernández Spain 25 804 0.6× 873 0.7× 482 0.5× 94 0.1× 224 0.5× 66 2.7k
Yao Sun United States 47 287 0.2× 2.6k 2.2× 1.9k 2.0× 532 0.7× 352 0.7× 188 8.0k
Masakazu Ishii Japan 26 474 0.4× 1.0k 0.9× 481 0.5× 243 0.3× 175 0.4× 69 2.8k
Micheline Duriez France 38 1.2k 0.9× 2.4k 2.0× 1.3k 1.4× 122 0.2× 1.1k 2.3× 59 5.6k
Albert Adam Canada 33 2.1k 1.5× 684 0.6× 192 0.2× 279 0.4× 652 1.3× 100 3.7k
Coralie Sengenès France 34 946 0.7× 1.3k 1.1× 1.1k 1.2× 170 0.2× 580 1.2× 56 5.8k
Toshinori Murayama Japan 35 426 0.3× 1.9k 1.6× 1.1k 1.1× 157 0.2× 678 1.4× 87 4.4k

Countries citing papers authored by Neil H Riordan

Since Specialization
Citations

This map shows the geographic impact of Neil H Riordan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil H Riordan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil H Riordan more than expected).

Fields of papers citing papers by Neil H Riordan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil H Riordan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil H Riordan. The network helps show where Neil H Riordan may publish in the future.

Co-authorship network of co-authors of Neil H Riordan

This figure shows the co-authorship network connecting the top 25 collaborators of Neil H Riordan. A scholar is included among the top collaborators of Neil H Riordan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil H Riordan. Neil H Riordan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández, Patricia L., et al.. (2023). Comparison of Cost and Potency of Human Mesenchymal Stromal Cell Conditioned Medium Derived from 2- and 3-Dimensional Cultures. Bioengineering. 10(8). 930–930. 3 indexed citations
2.
Miranda-Massari, Jorge R., et al.. (2021). The Effects of Vitamin C on the Multiple Pathophysiological Stages of COVID-19. Life. 11(12). 1341–1341. 9 indexed citations
3.
Riordan, Neil H, Nicole Allen, Neal E. Fearnot, et al.. (2018). Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis. Journal of Translational Medicine. 16(1). 57–57. 128 indexed citations
4.
Riordan, Neil H, Thomas E. Ichim, Hong Ma, et al.. (2016). Safety of targeting tumor endothelial cell antigens. Journal of Translational Medicine. 14(1). 90–90. 7 indexed citations
5.
González, Michael J., Jorge R. Miranda-Massari, Jorgé Duconge, Neil H Riordan, & Thomas E. Ichim. (2012). Schedule Dependence in Cancer Therapy: Intravenous Vitamin C and the Systemic Saturation Hypothesis.. PubMed. 27(1). 9–12. 3 indexed citations
6.
González, Michael J., Jorge R. Miranda-Massari, Jorgé Duconge, et al.. (2012). The bio-energetic theory of carcinogenesis. Medical Hypotheses. 79(4). 433–439. 23 indexed citations
7.
Ichim, Thomas E., Boris Minev, Todd A. Braciak, et al.. (2011). Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?. Journal of Translational Medicine. 9(1). 25–25. 22 indexed citations
8.
Alexandrescu, Doru T, Neil H Riordan, Thomas E. Ichim, et al.. (2011). On the missing link between inflammation and cancer. Dermatology Online Journal. 17(1). 10–10. 25 indexed citations
9.
Mikirova, Nina, et al.. (2011). EDTA chelation therapy in the treatment of toxic metals exposure. 1(2). 81–81. 12 indexed citations
10.
Mansilla, Eduardo, Gustavo H. Marín, Luis Núñez, et al.. (2010). The Lysosomotropic Agent, Hydroxychloroquine, Delivered in a Biodegradable Nanoparticle System, Overcomes Drug Resistance of B-Chronic Lymphocytic Leukemia Cells In Vitro. Cancer Biotherapy and Radiopharmaceuticals. 25(1). 97–103. 14 indexed citations
11.
Zhong, Zhaohui, Amit N. Patel, Thomas E. Ichim, et al.. (2009). Feasibility investigation of allogeneic endometrial regenerative cells. Journal of Translational Medicine. 7(1). 15–15. 109 indexed citations
12.
Mikirova, Nina, Thomas E. Ichim, & Neil H Riordan. (2008). Anti-angiogenic effect of high doses of ascorbic acid. Journal of Translational Medicine. 6(1). 50–50. 66 indexed citations
13.
Mikirova, Nina, et al.. (2008). Granulocyte activity in patients with cancer and healthy subjects. Cancer Biology & Therapy. 7(9). 1362–1367. 9 indexed citations
14.
Mikirova, Nina, Jackson James, & Neil H Riordan. (2008). Differential effect of alpha-lipoic acid on healthy peripheral blood lymphocytes and leukemic cells. 2 indexed citations
15.
Murphy, Michael P., Hao Wang, Amit N. Patel, et al.. (2008). Allogeneic endometrial regenerative cells: An "Off the shelf solution" for critical limb ischemia?. Journal of Translational Medicine. 6(1). 45–45. 125 indexed citations
16.
Ichim, Thomas E., Igor Popov, Neil H Riordan, et al.. (2006). A novel method of modifying immune responses by vaccination with lipiodol-siRNA mixtures. Journal of Translational Medicine. 4(1). 2–2. 7 indexed citations
17.
González, Michael J., Jorge R. Miranda-Massari, Edna Mora, et al.. (2005). Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later. Integrative Cancer Therapies. 4(1). 32–44. 105 indexed citations
18.
Casciari, Joseph J, Neil H Riordan, Thorsten Schmidt, et al.. (2001). Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. British Journal of Cancer. 84(11). 1544–1550. 80 indexed citations
19.
Riordan, Hugh D., et al.. (1998). HIGH-DOSE INTRAVENOUS VITAMIN C IN THE TREATMENT OF A PATIENT WITH RENAL CELL CARCINOMA OF THE KIDNEY. 13(2). 72–73. 25 indexed citations
20.
Riordan, Neil H, et al.. (1995). Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Medical Hypotheses. 44(3). 207–213. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noboru Fukuda Breakdown of academic impact, for papers by Román Pérez-Fernández Breakdown of academic impact, for papers by Yao Sun Breakdown of academic impact, for papers by Masakazu Ishii Breakdown of academic impact, for papers by Micheline Duriez Breakdown of academic impact, for papers by Albert Adam Breakdown of academic impact, for papers by Coralie Sengenès Breakdown of academic impact, for papers by Toshinori Murayama
Rankless by CCL
2026